Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06004063 · ClinicalTrials.gov registry record · NA
Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study
A NA study of Stem Cell, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT06004063 is a NA study of Stem Cell that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 3 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06004063, a NA study of Stem Cell, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to learn if feeding someone after a stem cell transplant is safe and practical.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Enteral nutrition (EN)
- OTHER Standard care parenteral nutrition (PN)
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-08-04 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06004063
The ClinicalTrials.gov registry entry for NCT06004063 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stem Cell appearing as the primary indexed condition, and to 2 interventions - of which Enteral nutrition (EN) is the first listed.
NCT06004063 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06004063 about?
NCT06004063 is a clinical study titled "Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study". The goal of this research study is to learn if feeding someone after a stem cell transplant is safe and practical.
What is the current status of trial NCT06004063?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3 participants. The study started on 2023-08-04. Estimated completion is 2029-12-31.
What conditions does trial NCT06004063 study?
This clinical trial studies the following conditions: Stem Cell.
What interventions are being tested in trial NCT06004063?
The interventions under investigation include: Enteral nutrition (EN) (DIETARY_SUPPLEMENT), Standard care parenteral nutrition (PN) (OTHER).
Who is sponsoring clinical trial NCT06004063?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06004063 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stem Cell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.